Myriad Genetics Inc (MYGN)
15.12
-0.18
(-1.18%)
USD |
NASDAQ |
Nov 21, 16:00
15.12
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Total Liabilities (Quarterly): 349.60M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 349.60M |
| June 30, 2024 | 344.60M |
| March 31, 2024 | 350.50M |
| December 31, 2023 | 363.30M |
| September 30, 2023 | 465.70M |
| June 30, 2023 | 452.00M |
| March 31, 2023 | 334.10M |
| December 31, 2022 | 312.90M |
| September 30, 2022 | 295.40M |
| June 30, 2022 | 262.80M |
| March 31, 2022 | 305.30M |
| December 31, 2021 | 352.90M |
| September 30, 2021 | 367.40M |
| June 30, 2021 | 457.90M |
| March 31, 2021 | 461.70M |
| September 30, 2020 | 535.20M |
| June 30, 2020 | 486.40M |
| March 31, 2020 | 479.50M |
| December 31, 2019 | 501.00M |
| September 30, 2019 | 516.70M |
| June 30, 2019 | 473.80M |
| March 31, 2019 | 475.60M |
| December 31, 2018 | 492.50M |
| September 30, 2018 | 471.40M |
| June 30, 2018 | 209.20M |
| Date | Value |
|---|---|
| March 31, 2018 | 270.10M |
| December 31, 2017 | 314.30M |
| September 30, 2017 | 357.70M |
| June 30, 2017 | 440.90M |
| March 31, 2017 | 519.90M |
| December 31, 2016 | 543.40M |
| September 30, 2016 | 535.60M |
| June 30, 2016 | 132.40M |
| March 31, 2016 | 98.00M |
| December 31, 2015 | 100.90M |
| September 30, 2015 | 99.90M |
| June 30, 2015 | 104.10M |
| March 31, 2015 | 110.15M |
| December 31, 2014 | 87.61M |
| September 30, 2014 | 96.86M |
| June 30, 2014 | 104.80M |
| March 31, 2014 | 94.18M |
| December 31, 2013 | 80.71M |
| September 30, 2013 | 91.39M |
| June 30, 2013 | 75.23M |
| March 31, 2013 | 64.10M |
| December 31, 2012 | 55.63M |
| September 30, 2012 | 67.49M |
| June 30, 2012 | 54.98M |
| March 31, 2012 | 47.06M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
262.80M
Minimum
Jun 2022
535.20M
Maximum
Sep 2020
393.59M
Average
363.30M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| ResMed Inc | 2.027B |
| Globus Medical Inc | 1.017B |
| Perspective Therapeutics Inc | 62.68M |
| Electromed Inc | 7.427M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.081B |
| Shareholders Equity (Quarterly) | 731.70M |
| Debt to Equity Ratio | 0.0533 |
| Current Ratio | 1.900 |
| Net Debt Paydown Yield | -0.00% |